Niox Group PLC Appointment of Financial Adviser and Joint Broker (0705A)
18 Januar 2024 - 8:00AM
UK Regulatory
TIDMNIOX
RNS Number : 0705A
Niox Group PLC
18 January 2024
NIOX GROUP PLC
("NIOX" or the "Company" )
Appointment of Financial Adviser and Joint Broker
Oxford, UK - 18 January 2024: NIOX Group plc (AIM: NIOX), a
company engaged in the design, development and commercialisation of
medical devices for asthma diagnosis and management, today
announces the appointment of Investec Bank plc as the Company's
financial adviser and joint broker with immediate effect. Singer
Capital Markets continues to act as the Company's nominated adviser
and corporate broker.
Contacts
NIOX Tel: +44 (0) 1865
405 560
Ian Johnson, Executive Chairman
Michael Roller, Chief Financial Officer
Singer Capital Markets (Nominated Adviser and Tel: +44 (0) 20 7496
j oint broker) 3000
Aubrey Powell / Jen Boorer / Alaina Wong
I nvestec Bank plc Tel: +44 (0) 20 7597
4000
Edward Knight / Bruce Garrow / Lydia Zychowska
About NIOX
Our mission is to improve asthma diagnosis and management by
greater patient access to FeNO testing. Asthma is one of the
biggest healthcare issues globally with 340 million sufferers, many
of whom are undiagnosed or are misdiagnosed. The Group is engaged
in the design, development, and commercialisation of medical
devices for the measurement of FeNO, a precise biomarker for
asthma. Our market leading device, NIOX VERO (R) , is increasingly
recognised by healthcare professionals as an important tool to
improve the diagnosis and management of asthma. NIOX VERO (R) is
also the device of choice by leading clinical research
organisations for respiratory studies.
NIOX provides products and services via its direct sales
organisation and extensive distributor network in 50
countries. For more information, please visit www.niox.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
APPFLFSTLRIDLIS
(END) Dow Jones Newswires
January 18, 2024 02:00 ET (07:00 GMT)
Niox (LSE:NIOX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Niox (LSE:NIOX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024